| 1 |
Betaferon |
- |
- |
- |
- |
013 [1] 13 💬 |
| 2 |
Betaferon 250 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 3 |
Betaferon 250 microgram/ml |
- |
- |
- |
- |
013 [1] 13 💬 |
| 4 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection |
- |
- |
- |
- |
013 [1] 13 💬 |
| 5 |
Betaferon 250 microgram/ml, powder and solvent for solution for injection. |
- |
- |
- |
- |
013 [1] 13 💬 |
| 6 |
Betaferon 250 microgramos |
- |
- |
- |
- |
013 [1] 13 💬 |
| 7 |
Betaferon 250mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 8 |
Betaferon 250µg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 9 |
Betaferon 500 mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 10 |
Betaferon 500 µg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 11 |
Betaferon 500mcg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 12 |
Betaferon 500µg |
- |
- |
- |
- |
013 [1] 13 💬 |
| 13 |
Betaferon sc 15f 0,25mg 15sir |
- |
- |
- |
- |
013 [1] 13 💬 |
| 14 |
Betaferon*15confez 0,25mg/ml+ |
- |
- |
- |
- |
013 [1] 13 💬 |
| 15 |
Betaferon, bay 86-5046 |
- |
- |
- |
- |
013 [1] 13 💬 |
| 16 |
Betaferon/betaseron |
- |
- |
- |
- |
013 [1] 13 💬 |
| 17 |
Betaferon® |
- |
- |
- |
- |
013 [1] 13 💬 |
| 18 |
Betaferon® (interferon beta-1b) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
| 19 |
Interferon beta 1-b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
- |
- |
- |
013 [1] 13 💬 |
| 20 |
Interferon beta-1b (betaferon, bay 86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
| 21 |
Interferon beta-1b (betaferon, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
| 22 |
Interferon beta-1b (betaferon/betaseron, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
| 23 |
Interferon beta-1b (betaferon®, bay 86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
| 24 |
Interferon beta-1b (betaseron, betaferon, bay86-5046) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |
| 25 |
Interferon beta-1b (pf530, betaferon) |
Human interferon beta |
[1] D00746 D00746 💬 |
IFNAR1 [2] IFNAR1, IFNAR2 💬 |
Coronavirus disease - COVID-19 [18] Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway |
013 [1] 13 💬 |